These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 4360755

  • 1. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P.
    Schweiz Med Wochenschr; 1974 Feb 23; 104(8):268-71. PubMed ID: 4360755
    [No Abstract] [Full Text] [Related]

  • 2. Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma.
    Alberto P.
    Cancer Chemother Rep 3; 1973 Mar 23; 4(2):199-206. PubMed ID: 4729321
    [No Abstract] [Full Text] [Related]

  • 3. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
    Ryssel HJ, Hasler E, Sonntag RW, Cavalli F, Martin J, Tschopp L, Brunner KW.
    Schweiz Med Wochenschr; 1977 Jul 02; 107(26):912-5. PubMed ID: 877537
    [Abstract] [Full Text] [Related]

  • 4. [Cytostatic therapy of tumors of the lung].
    De Marco F, Saviano G, Tenore G.
    Arch Monaldi; 1974 Jul 02; 29(3-4):326-35. PubMed ID: 4463917
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Combination chemotherapy of small cell bronchial carcinomas. Complete remissions].
    Mannes P, Derriks R, Mannes R.
    Lille Med; 1978 May 02; 23(3):187-91. PubMed ID: 206794
    [No Abstract] [Full Text] [Related]

  • 7. Combination chemotherapy and radiation therapy for small cell carcinoma of the lung.
    Maurer LH, Tulloh M, Eagan RT, Forcier RJ, House R.
    Cancer Chemother Rep 3; 1973 Mar 02; 4(2):171-6. PubMed ID: 4354041
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine.
    Alberto P, Brunner KW, Martz G, Obrecht J, Sonntag RW.
    Cancer; 1976 Dec 02; 38(6):2208-16. PubMed ID: 187313
    [Abstract] [Full Text] [Related]

  • 11. [Cancer chemotherapy of inoperable bronchial carcinomas (author's transl)].
    Rieche K.
    Z Erkr Atmungsorgane; 1975 Feb 02; 142(2):140-8. PubMed ID: 179223
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chemotherapy of bronchogenic carcinomas by a combination of cyclophosphamide, methotrexate, vincristin and bleomycin.
    Schaerer R, Sotto JJ, Wiget U, Perdrix A, Bensa JC, Ribaud P.
    Eur J Cancer (1965); 1977 Feb 02; 13(4-5):425-8. PubMed ID: 68881
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
    Perevodchikova NI, Bychkov MB.
    Cancer Chemother Rep 3; 1973 Mar 02; 4(2):251-5. PubMed ID: 4199645
    [No Abstract] [Full Text] [Related]

  • 19. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Bitran JD, Desser RK, DeMeester T, Golomb HM.
    JAMA; 1978 Dec 15; 240(25):2743-6. PubMed ID: 713008
    [Abstract] [Full Text] [Related]

  • 20. [Polychemotherapy of bronchopulmonary cancer].
    Morere P, Chauvet MC, Vaudour P, Maisse P, Stain JP, Lenail C.
    Poumon Coeur; 1968 Dec 15; 24(1):111-6. PubMed ID: 5661796
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.